サマリー

スマート吸入器技術の世界市場 2023-2027
スマート吸入器技術市場は、2022年から2027年にかけて4637万米ドルの成長が予測され、予測期間中のCAGRは10.16%で加速する。この調査レポートは、スマート吸入器技術市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、呼吸器疾患の有病率の上昇、コネクテッドヘルスケアシステムに対する需要の高まり、医療費の増加によって牽引されています。
Technavio社のスマート吸入器技術市場は以下のように区分されます：
製品別
- 吸入器
- ネブライザー
用途別
- 喘息
- COPD（慢性閉塞性肺疾患
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、リアルタイムのフィードバックが利用可能であることが、今後数年間のスマート吸入器技術市場の成長を促進する主要な理由の1つであると特定している。また、ヘルスケアのデジタル化の進展と技術的進歩の高まりは、市場の大きな需要につながる。
当レポートでは、スマート吸入器技術市場について、以下の分野をカバーしています：
- スマート吸入器技術市場のサイジング
- スマート吸入器技術市場の予測
- スマート吸入器技術市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つよう設計されており、これに沿って、本レポートでは、3M Co、Amiko Digital Health Ltd.、AptarGroup Inc.、AstraZeneca Plc、Cognita Labs、Cohero Health Inc.、Findair Sp. z o.o.、Infineon Technologies AG、Novartis AG、OPKO Health Inc.、ResMed Inc.、Sensirion AG、Teva Pharmaceutical Industries Ltd.、Vectura Group plcなどです。また、スマート吸入器技術市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
この調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/smart-inhaler-technology-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global smart inhaler technology market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global smart inhaler technology market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Inhalers - Market size and forecast 2022-2027
o Exhibit 34: Chart on Inhalers - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Inhalers - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
o 6.4 Nebulizers - Market size and forecast 2022-2027
o Exhibit 38: Chart on Nebulizers - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Nebulizers - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Nebulizers - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Nebulizers - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Asthma - Market size and forecast 2022-2027
o Exhibit 48: Chart on Asthma - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Asthma - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Asthma - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
o 7.4 COPD - Market size and forecast 2022-2027
o Exhibit 52: Chart on COPD - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on COPD - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on COPD - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on COPD - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Application
o Exhibit 56: Market opportunity by Application ($ million)
o Exhibit 57: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 83: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 France - Market size and forecast 2022-2027
o Exhibit 87: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 3M Co.
o Exhibit 107: 3M Co. - Overview
o Exhibit 108: 3M Co. - Business segments
o Exhibit 109: 3M Co. - Key news
o Exhibit 110: 3M Co. - Key offerings
o Exhibit 111: 3M Co. - Segment focus
o 12.4 Adherium Ltd.
o Exhibit 112: Adherium Ltd. - Overview
o Exhibit 113: Adherium Ltd. - Product / Service
o Exhibit 114: Adherium Ltd. - Key offerings
o 12.5 Amiko Digital Health Ltd.
o Exhibit 115: Amiko Digital Health Ltd. - Overview
o Exhibit 116: Amiko Digital Health Ltd. - Product / Service
o Exhibit 117: Amiko Digital Health Ltd. - Key offerings
o 12.6 AptarGroup Inc.
o Exhibit 118: AptarGroup Inc. - Overview
o Exhibit 119: AptarGroup Inc. - Business segments
o Exhibit 120: AptarGroup Inc. - Key offerings
o Exhibit 121: AptarGroup Inc. - Segment focus
o 12.7 AstraZeneca Plc
o Exhibit 122: AstraZeneca Plc - Overview
o Exhibit 123: AstraZeneca Plc - Product / Service
o Exhibit 124: AstraZeneca Plc - Key news
o Exhibit 125: AstraZeneca Plc - Key offerings
o 12.8 Cognita Labs
o Exhibit 126: Cognita Labs - Overview
o Exhibit 127: Cognita Labs - Product / Service
o Exhibit 128: Cognita Labs - Key offerings
o 12.9 Cohero Health Inc.
o Exhibit 129: Cohero Health Inc. - Overview
o Exhibit 130: Cohero Health Inc. - Product / Service
o Exhibit 131: Cohero Health Inc. - Key offerings
o 12.10 Findair Sp. z o. o.
o Exhibit 132: Findair Sp. z o. o. - Overview
o Exhibit 133: Findair Sp. z o. o. - Product / Service
o Exhibit 134: Findair Sp. z o. o. - Key offerings
o 12.11 Infineon Technologies AG
o Exhibit 135: Infineon Technologies AG - Overview
o Exhibit 136: Infineon Technologies AG - Business segments
o Exhibit 137: Infineon Technologies AG - Key news
o Exhibit 138: Infineon Technologies AG - Key offerings
o Exhibit 139: Infineon Technologies AG - Segment focus
o 12.12 Novartis AG
o Exhibit 140: Novartis AG - Overview
o Exhibit 141: Novartis AG - Business segments
o Exhibit 142: Novartis AG - Key offerings
o Exhibit 143: Novartis AG - Segment focus
o 12.13 OPKO Health Inc.
o Exhibit 144: OPKO Health Inc. - Overview
o Exhibit 145: OPKO Health Inc. - Business segments
o Exhibit 146: OPKO Health Inc. - Key offerings
o Exhibit 147: OPKO Health Inc. - Segment focus
o 12.14 ResMed Inc.
o Exhibit 148: ResMed Inc. - Overview
o Exhibit 149: ResMed Inc. - Business segments
o Exhibit 150: ResMed Inc. - Key news
o Exhibit 151: ResMed Inc. - Key offerings
o Exhibit 152: ResMed Inc. - Segment focus
o 12.15 Sensirion AG
o Exhibit 153: Sensirion AG - Overview
o Exhibit 154: Sensirion AG - Product / Service
o Exhibit 155: Sensirion AG - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Vectura Group plc
o Exhibit 161: Vectura Group plc - Overview
o Exhibit 162: Vectura Group plc - Product / Service
o Exhibit 163: Vectura Group plc - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 164: Inclusions checklist
o Exhibit 165: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 166: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 167: Research methodology
o Exhibit 168: Validation techniques employed for market sizing
o Exhibit 169: Information sources
o 13.5 List of abbreviations
o Exhibit 170: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global smart inhaler technology market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Inhalers - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Inhalers - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Nebulizers - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Nebulizers - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Nebulizers - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Nebulizers - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Asthma - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Asthma - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Asthma - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on COPD - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on COPD - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on COPD - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on COPD - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Application ($ million)
Exhibits57: Data Table on Market opportunity by Application ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: 3M Co. - Overview
Exhibits108: 3M Co. - Business segments
Exhibits109: 3M Co. - Key news
Exhibits110: 3M Co. - Key offerings
Exhibits111: 3M Co. - Segment focus
Exhibits112: Adherium Ltd. - Overview
Exhibits113: Adherium Ltd. - Product / Service
Exhibits114: Adherium Ltd. - Key offerings
Exhibits115: Amiko Digital Health Ltd. - Overview
Exhibits116: Amiko Digital Health Ltd. - Product / Service
Exhibits117: Amiko Digital Health Ltd. - Key offerings
Exhibits118: AptarGroup Inc. - Overview
Exhibits119: AptarGroup Inc. - Business segments
Exhibits120: AptarGroup Inc. - Key offerings
Exhibits121: AptarGroup Inc. - Segment focus
Exhibits122: AstraZeneca Plc - Overview
Exhibits123: AstraZeneca Plc - Product / Service
Exhibits124: AstraZeneca Plc - Key news
Exhibits125: AstraZeneca Plc - Key offerings
Exhibits126: Cognita Labs - Overview
Exhibits127: Cognita Labs - Product / Service
Exhibits128: Cognita Labs - Key offerings
Exhibits129: Cohero Health Inc. - Overview
Exhibits130: Cohero Health Inc. - Product / Service
Exhibits131: Cohero Health Inc. - Key offerings
Exhibits132: Findair Sp. z o. o. - Overview
Exhibits133: Findair Sp. z o. o. - Product / Service
Exhibits134: Findair Sp. z o. o. - Key offerings
Exhibits135: Infineon Technologies AG - Overview
Exhibits136: Infineon Technologies AG - Business segments
Exhibits137: Infineon Technologies AG - Key news
Exhibits138: Infineon Technologies AG - Key offerings
Exhibits139: Infineon Technologies AG - Segment focus
Exhibits140: Novartis AG - Overview
Exhibits141: Novartis AG - Business segments
Exhibits142: Novartis AG - Key offerings
Exhibits143: Novartis AG - Segment focus
Exhibits144: OPKO Health Inc. - Overview
Exhibits145: OPKO Health Inc. - Business segments
Exhibits146: OPKO Health Inc. - Key offerings
Exhibits147: OPKO Health Inc. - Segment focus
Exhibits148: ResMed Inc. - Overview
Exhibits149: ResMed Inc. - Business segments
Exhibits150: ResMed Inc. - Key news
Exhibits151: ResMed Inc. - Key offerings
Exhibits152: ResMed Inc. - Segment focus
Exhibits153: Sensirion AG - Overview
Exhibits154: Sensirion AG - Product / Service
Exhibits155: Sensirion AG - Key offerings
Exhibits156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits161: Vectura Group plc - Overview
Exhibits162: Vectura Group plc - Product / Service
Exhibits163: Vectura Group plc - Key offerings
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations